Zydus Cadila India covid-19 Zydus Cadila India

India's Zydus Cadila signs pact with Gilead to make remdesivir

Reading now: 171
www.livemint.com

BENGALURU : Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA